轻微型肝性脑病的研究进展与中医治疗(4)
[6]Bajaj JS，Cordoba J，Mullen KD，et al.Review article：the design of clinical trials in hepatic encephalopathy——an International Society for Hepatic Encephalopathy and Nitrogen Metabolism(ISHEN)consensus statement[J].Aliment Pharmacol Ther，2011，33(7)：739-747.
[7]Mina A，Moran S，Ortiz-Olvera N，et al.Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis[J].Hepatol Res，2014，44(10)：E92-99.
, http://www.100md.com
[8]李素文，许建明，胡凯风，等.轻微肝性脑病患病情况调查及相关危险因素分析[J].胃肠病学和肝病学杂志，2012，21(2)：176-179.
[9]Wang JY，Zhang NP，Chi BR，et al.Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China[J].World J Gastroenterol，2013，19(30)：4984-4991.
[10]Tan HH，Lee GH，Thia KT，et al.Minimal hepatic encephalopathy runs a fluctuating course：results from a three-year prospective cohort follow-up study[J].Singapore Med J，2009，50(3)：255-260.
, 百拇医药
[11]吴娟.幽门螺杆菌在轻微肝性脑病发病机制中的作用及HP根治治疗后临床影响[J].中华医院感染学杂志，2013，23(15)：3642-3644.
[12]张庆武，苏德望.谷氨酰胺对大鼠梗阻性黄疸内毒素血症影响的实验研究[J].局解手术学杂志，2009，18(5)：316-318.
[13]Velissaris D，Karanikolas M，Kalogeropoulos A，et al.Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy[J].World J Gastroenterol，2008，14(26)：4190-4195.
[14]Ciecko-Michalska I，Wojcik J，Wyczesany M，et al.Cognitive evoked response potentials in patients with live cirrhosis without diagnosis of minimal or overt hepatic encephalopathy.A pilot study[J].J Physiol Pharmacol，2012，63(3)：271-276.
, http://www.100md.com
[15]Sharma P，Sharma BC，Sarin SK.Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis[J].Liver Int，2009，29(9)：1365-1371.
[16]Montoliu C，Cauli O，Urios A，et al.3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis[J].Am J Gastroenterol，2011，106(9)：1629-1637.
[17]Kato A，Suzuki K，Kaneta H，et al.Regional differences in cerebral glucose metabolism in cirrhotic patients with subclinical hepatic encephalopathy using positron emission tomography[J].Hepatol Res，2000，17(3)：237-245.
, 百拇医药
[18]Bajaj JS.Minimal hepatic encephalopathy matters in daily life[J].World J Gastroenterol，2008，14(23)：3609-3615.
[19]楊健全，武淑环，李志勤，等.轻微肝性脑病的治疗进展[J].医药论坛杂志，2010，31(23)：196-197，200.
[20]Kato A，Tanaka H，Kawaguchi T，et al.Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis：A preliminary，prospective，open-label study[J].Hepatol Res，2013，43(5)：452-458., http://www.100md.com(郭琲婷 郭晓霞)
[7]Mina A，Moran S，Ortiz-Olvera N，et al.Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis[J].Hepatol Res，2014，44(10)：E92-99.
, http://www.100md.com
[8]李素文，许建明，胡凯风，等.轻微肝性脑病患病情况调查及相关危险因素分析[J].胃肠病学和肝病学杂志，2012，21(2)：176-179.
[9]Wang JY，Zhang NP，Chi BR，et al.Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China[J].World J Gastroenterol，2013，19(30)：4984-4991.
[10]Tan HH，Lee GH，Thia KT，et al.Minimal hepatic encephalopathy runs a fluctuating course：results from a three-year prospective cohort follow-up study[J].Singapore Med J，2009，50(3)：255-260.
, 百拇医药
[11]吴娟.幽门螺杆菌在轻微肝性脑病发病机制中的作用及HP根治治疗后临床影响[J].中华医院感染学杂志，2013，23(15)：3642-3644.
[12]张庆武，苏德望.谷氨酰胺对大鼠梗阻性黄疸内毒素血症影响的实验研究[J].局解手术学杂志，2009，18(5)：316-318.
[13]Velissaris D，Karanikolas M，Kalogeropoulos A，et al.Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy[J].World J Gastroenterol，2008，14(26)：4190-4195.
[14]Ciecko-Michalska I，Wojcik J，Wyczesany M，et al.Cognitive evoked response potentials in patients with live cirrhosis without diagnosis of minimal or overt hepatic encephalopathy.A pilot study[J].J Physiol Pharmacol，2012，63(3)：271-276.
, http://www.100md.com
[15]Sharma P，Sharma BC，Sarin SK.Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis[J].Liver Int，2009，29(9)：1365-1371.
[16]Montoliu C，Cauli O，Urios A，et al.3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis[J].Am J Gastroenterol，2011，106(9)：1629-1637.
[17]Kato A，Suzuki K，Kaneta H，et al.Regional differences in cerebral glucose metabolism in cirrhotic patients with subclinical hepatic encephalopathy using positron emission tomography[J].Hepatol Res，2000，17(3)：237-245.
, 百拇医药
[18]Bajaj JS.Minimal hepatic encephalopathy matters in daily life[J].World J Gastroenterol，2008，14(23)：3609-3615.
[19]楊健全，武淑环，李志勤，等.轻微肝性脑病的治疗进展[J].医药论坛杂志，2010，31(23)：196-197，200.
[20]Kato A，Tanaka H，Kawaguchi T，et al.Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis：A preliminary，prospective，open-label study[J].Hepatol Res，2013，43(5)：452-458., http://www.100md.com(郭琲婷 郭晓霞)